QuantumLight, the venture capital firm created by Revolut co‑founder Nikolay Storonsky, closed a $500 million second fund, twice the size of its first fund, to back high‑growth tech companies across AI, crypto, fintech, SaaS and healthtech. The fund is managed by CEO Ilya Kondrashov and will use an AI‑driven selection platform called Aleph to pick investments.
Attuned combines smartphone haptics, guided audio and live video connections with trained human “Anchors” to help users regulate stress and anxiety. After a pilot with 150 users, the startup is moving to a public beta later in 2026, aiming to scale human‑to‑human connection as a service.
The article interviews Dr. Aleksandra Staniszewska, CEO of MY OVU, about the company’s new medical device that continuously monitors body temperature to provide more accurate data for women’s health, especially during early morning hours. The device is wireless, measures temperature every four minutes, and is positioned as a superior alternative to traditional fertility calendar apps.
Founder Stephanie Spindler Jonsson’s startup Mypauze, which aims to reduce screen time, has seen a surge in sales and is now profitable.
Polish Deputy Prime Minister and Minister of Digitisation Krzysztof Gawkowski confirmed that a database containing close to 19 million patient records was stolen from MyDr, affecting patients across the entire country.
Luxembourg‑based space biotech startup Exobiosphere received a €1 million grant from the government’s JEI programme to accelerate its commercial activities and develop its orbital high‑throughput screening system for drug discovery in microgravity.
Austrian startup Efferon, founded in 2016, creates blood‑purification cartridges that remove bacterial toxins and inflammatory mediators to treat sepsis. After receiving European CE MDR approval for its adult device in 2024 and paediatric certification in 2026, the devices have been used in over 25,000 treatments in 44 countries, generating more than €1 million in revenue. Efferon is now pursuing US regulatory pathways, expanding into China, and developing an outpatient solution for post‑sepsis and chronic inflammation.
Hamburg‑based biotech startup AquaNab raised an early‑stage investment from Nordic Foodtech VC to develop precision nanoantibodies that can be fed to salmon to combat sea lice, aiming to improve fish welfare and reduce industry losses.
eB2 MindCare has introduced an AI‑driven platform that continuously tracks emotional wellbeing without invasive methods, converting passive data into behavioural biomarkers and predictive alerts to help healthcare providers anticipate risks and make better clinical decisions.
DokterOnline, a Dutch e‑health platform, used visitor‑behavior data to create five behavioral segments and adjusted a few homepage elements (hero, featured treatments, recommended articles) for each segment. The modest changes boosted overall visitor engagement by over 15% and increased the click‑through rate of personalized content by about 83%, demonstrating that small, data‑driven personalization can significantly improve user experience without large technical investments.